Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 8,921 | 2,207 | 2,008 | 2,019 | 1,015 |
| Operating Income | -8,921 | -2,207 | -2,008 | -2,019 | -1,015 |
| Other Income | -9,601 | -12 | -13 | -14 | -5 |
| Pre-tax Income | -18,522 | -2,218 | -2,020 | -2,033 | -1,019 |
| Net Income Continuous | -18,522 | -2,218 | -2,020 | -2,033 | -1,019 |
| Net Income | $-18,522 | $-2,218 | $-2,020 | $-2,033 | $-1,019 |
| EPS Basic Total Ops | -5,022.49 | -899.55 | -824.59 | -899.55 | -449.78 |
| EPS Basic Continuous Ops | -4,994.63 | -944.95 | -859.11 | -866.93 | -436.54 |
| EPS Diluted Total Ops | -5,022.49 | -899.55 | -824.59 | -899.55 | -449.78 |
| EPS Diluted Continuous Ops | -4,994.63 | -944.95 | -859.11 | -866.93 | -436.54 |
| EBITDA(a) | $-8,826 | $-2,182 | $-1,982 | $-1,995 | $-992 |